QQ客服 官方微博 反馈留言

浏览/检索结果: 共9条，第1-9条 帮助 限定条件 发表日期：2017    内容类型：会议论文     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Genome-Wide Screen of DNA Methylation Changes Reveals GABBR2 as a Novel Potential Target for EGFR 19 Deletion Adenocarcinoma with Erlotinib 会议论文 作者:  Liu, Fatao;  Zhou, Yi;  Zhou, Zhen;  Liu, Yun;  Chen, Zhiwei 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)  lung adenocarcinoma  methyl-sensitive cut counting sequencing (MSCC)  methylation   A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naive Patients with EGFRm plus NSCLC: An Interim Analysis 会议论文 作者:  Wu, Y.;  Tu, H.;  Feng, J.;  Shi, M.;  Zhao, J. 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05 afatinib  EGFR  NSCLC   A Phase I Dose Expansion Study of Epitinib to Evaluate Efficacy and Safety in EGFR Mutation Positive (EGFRm plus ) NSCLC Patients with Brain Metastasis 会议论文 作者:  Zhou, Qing;  Gan, Bin;  Hong, Qunying;  Wang, Mengzhao;  Liu, Xiaoqing 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05 NSCLC  Brain metastasis  EGFR TKI  Dose expansion study   Pharmacokinetics of Osimertinib (AZD9291) in Chinese Patients with Advanced NSCLC: A Phase I Study 会议论文 作者:  Cao, Junning;  Chang, Jianhua;  Zhang, Clara;  Leaw, Shiang Jiin;  Wang, Jia 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 pharmacokinetics  osimertinib  EGFR-TKI  T790M   Early predictive and prognostic value of F-18-FDG PET/CT for response assessment in non-small cell lung cancer treated with EGFR-TKI 会议论文 JOURNAL OF NUCLEAR MEDICINE, 2017-05-01 作者:  Lyu, Lyu;  Wu, Ning;  Ying, Liu;  Yan, Fang;  Li Xiaomeng 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03 Open label, multi-center, prospective study to investigate the efficacy and safety of osimertinib in brain metastases from patients with EGFR T790M positive NSCLC who have received prior therapy with an EGFR-TKI (APOLLO Study, NCT02972333) 会议论文 ANNALS OF ONCOLOGY, 2017-04-01 作者:  Wang, L.;  Xing, L.;  Cao, L.;  Wang, X.;  Feng, J. 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04 An updated analysis of ICOGEN to demonstrate utility of a blood-based proteomic test to predict outcomes in EGFR TKI treated patients. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20 作者:  Shi, Yuankai;  Han, Xiaohong;  Zhang, Li;  Ding, Lieming;  Dupuis, Nicholas 收藏  |  浏览/下载：6/0  |  提交时间：2020/01/04 Quantitative CBCT Parameters for Evaluation EGFR Mutation Status and Prediction EGFR-TKI Response in Patients with Lung Adenocarcinoma 会议论文 59th Annual Meeting and Exhibition of the American-Association-of-Physicists-in-Medicine (AAPM), JUL 30-AUG 03, 2017 作者:  Wen, Q.;  Zhu, J.;  Meng, X.;  Yin, Y.;  Yu, J. 收藏  |  浏览/下载：15/0  |  提交时间：2019/12/31 Open label, multi-center, prospective study to investigate the efficacy and safety of osimertinib in brain metastases from patients with EGFR T790M positive NSCLC who have received prior therapy with an EGFR-TKI (APOLLO Study, NCT02972333) 会议论文 European Lung Cancer Conference (ELCC), MAY 05-08, 2017 作者:  Wang, L.;  Xing, L.;  Cao, L.;  Wang, L.;  Wang, X. 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/31